According to FutureWise analysis the market for hpv testing and pap test in 2023 is US$ 5.56 billion, and is expected to reach US$ 15.22 billion by 2031 at a CAGR of 13.42%.
HPV is a sexually transmitted virus which is the rpiamry reason for causing cervical cancer. Over 85% of all cervical and anal cancers and over 65% of vulvar and vaginal cancers are caused due to HPV. PAP tests are majorly used for detecting cervical cancer. These include specimen observation at a microscopic level. The rising number of patients diagnosed with cervical cancer, the growing geriatric population, the increased awaareness pertaining to the screening programs of cervical cancer are some ket driving facotrsd contributing to the growth of the market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of the market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.